All News about Dexcom Inc
![](/next-assets/images/schema-image-default.png)
Check Out What Whales Are Doing With DXCM
April 28, 2023
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2016/04/SSA-040816-shutterstock.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/28/roblox_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/28/mastercard_-_logo.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2020/02/stock-Dexcom-02-shutter.jpg)
![](https://g.foolcdn.com/editorial/images/729559/pharmacist-talking-to-patient.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/28/dxcm.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230427005220/en/1474219/22/New_Dexcom_Logo.jpg)
Dexcom Reports First Quarter 2023 Financial Results
April 27, 2023
From DexCom, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20230427005246/en/1776192/22/GG1_0630_%281%29.jpg)
![](https://images.pexels.com/photos/5849595/pexels-photo-5849595.jpeg?auto=compress&cs=tinysrgb&dpr=1&w=500)
![](/next-assets/images/schema-image-default.png)
P/E Ratio Insights for DexCom
April 25, 2023
Via Benzinga
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Where DexCom Stands With Analysts
April 17, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/729183/doctor-with-senior-man_gettyimages-1147479334.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/25/screenshot_2023-04-25_at_5.18.16_pm.png?width=1200&height=800&fit=crop)
![](https://www.marketbeat.com/logos/articles/med_20230417140747_three-medtech-companies-with-future-higher-share-p.jpg)
![](https://www.investors.com/wp-content/uploads/2021/01/Stock-Tesla-modelY-01-adobe.jpg)
![](/next-assets/images/schema-image-default.png)
What To Know About Raymond James's Upgrade of DexCom
April 17, 2023
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2023/03/Stock-dexcom-one-04-adobe.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230419092321_diversified-abbott-laboratories-could-reverse-and.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/17/dxcm.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/17/visa_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://www.marketbeat.com/logos/articles/med_20230417071050_healthcare-innovation-drives-medical-device-makers.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://mms.businesswire.com/media/20230417005229/en/1764619/22/Dexcom_G7_Medicare_Couple.jpg)
![](https://g.foolcdn.com/editorial/images/727550/a-couple-walking-and-looking-at-a-cell-phone.jpg)
![](https://g.foolcdn.com/editorial/images/727338/paper-certificate-shares-invest-stock-split-market-reverse-getty.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.